Levothyroxine sodium Aristo 150 micrograms tablets

Licence holder

Aristo Pharma GmbH (all products →)

Active substance

Levothyroxine Sodium Anhydrous EP

Dosage form

Tablet

Route of administration

Oral use

ATC code

H03AA01

First authorised

12/08/2022

Prescription status

Product subject to prescription which may be renewed (B)

Supply

Supply through pharmacies only

Legal basis

Hybrid application (Article 10(3) of Directive No 2001/83/EC)

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.